Avvisi di selezione per i BIP Translational research in MDR: how to move from preclinical research to clinical benefits –e Drug development, repurposing and formulation against MDR, and relative toxicological aspects -DesignDrugs2MDR: scadenza  prorogata al 10 gennaio 2025